| Barbados | | |
Tuberculosis incidence (per 100,000 population) | 0.4 (2021) [195/198countries] | | | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | 0.2 (2020) [100/194countries] | | | Reported number of people requiring interventions against NTDs | 448 (2021) [3/83countries] | | | Probability of dying from any of CVD, cancer, diabetes, CRD between age 30-70 (%) | 16.0 (2019) [126/183countries] | | |
|
| Barbados | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 219.2 (2020) [55/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 1.3 (2020) [164/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 1.1 (2020) [151/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 82.1 (2020) [21/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 15.2 (2020) [87/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 51.2 (2020) [44/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 20.4 (2020) [11/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.6 (2020) [100/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 4.3 (2020) [61/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 1.0 (2020) [134/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 6.6 (2020) [48/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 1.4 (2020) [132/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 2.3 (2020) [178/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 10.9 (2020) [100/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 3.2 (2020) [108/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 6.3 (2020) [1/178countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 7.8 (2020) [64/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 0.8 (2020) [166/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.8 (2020) [70/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 7.9 (2020) [46/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 6.0 (2020) [57/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 110.3 (2020) [4/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 4.8 (2020) [114/184countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 3.5 (2020) [101/184countries] | | |
|
| Barbados | | |
Suicide, age-standardized (per 100 000 population) | 0.31 (2019) [183/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 0.49 (2019) [182/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 0.16 (2019) [183/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 0.00 (2019) [180/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 0.00 (2019) [180/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 0.00 (2019) [179/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 0.00 (2019) [181/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 0.00 (2019) [181/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 0.00 (2019) [179/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 0.35 (2019) [181/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 0.72 (2019) [181/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 0.00 (2019) [178/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 0.71 (2019) [180/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 1.48 (2019) [180/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 0.00 (2019) [180/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 0.00 (2019) [180/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 0.00 (2019) [179/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 0.00 (2019) [180/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 0.00 (2019) [180/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 0.00 (2019) [180/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 0.00 (2019) [179/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 3.39 (2019) [179/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 0.00 (2019) [180/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 5.92 (2019) [116/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 0.00 (2019) [179/183countries] | | |
|
| Barbados | | |
Density of medical doctors (per 10,000 population) | 25.5 (2013?2021) [67/192countries] | | | Density of nursing and midwifery personnel (per 10,000 population) | 31.4 (2013?2021) [107/195countries] | | | Density of dentists (per 10,000 population) | 3.2 (2013?2021) [80/171countries] | | | Hospital beds (number per 1,000 population) | 6.0 (2017) [13/110countries] | | | Population with household expenditures on health > 10% of total household expenditure or income (%) | 16.4 (2013?2021) [17/132countries] | | |
|
|